期刊文献+

常规分割三维适形放疗结合介入治疗肝细胞癌伴门静脉癌栓的疗效 被引量:6

The effect of 3-dimensional conformal radiation in conventional dose with transcatheter arterial chemoembolization in treatment of HCC together with portal thrombus
暂未订购
导出
摘要 目的肝细胞癌伴门静脉癌栓预后极差,本研究的目的是评价常规分割三维适形放射治疗结合经皮介入肝动脉化疗栓塞治疗肝细胞癌伴门静脉癌栓的疗效。方法对32例不能手术切除的肝细胞癌伴门静脉癌栓患者采用三维适形放射治疗结合经皮介入肝动脉化疗栓塞治疗,三维适形放射治疗采用DT2 Gy/次,5次/周;根据肿瘤体积大小,给予DT45 Gy^60 Gy/23~30次,对于肿瘤体积比较大,不能耐受高剂量放射治疗的病人,在肝细胞癌伴门静脉癌栓达到处方剂量后,缩野针对门静脉癌栓加量至DT60 Gy/30次。观察近期疗效,用Kaplan-Meier法进行生存分析,采用COX比例风险模型作多因素分析。结果原发灶肿瘤缓解率68.8%,门静脉癌栓缓解率87.5%,1、2、3年累积生存率分别是56.3%、31.3%、21.9%,中位生存期15个月。多因素分析显示卡氏评分、Child分级是影响预后的主要因素(P<0.05)。血清转氨酶升高和放射性肝损伤是常见的并发症。结论常规分割三维适形放射治疗结合经皮介入肝动脉化疗栓塞治疗肝细胞癌伴门静脉癌栓有较好的疗效,肝功能Child分级、卡氏评分是影响预后的主要因素。 Objective Prognosis of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTr) is extremely poor. The study evaluates the curative effect that 3 - dimensional conformal radiation therapy in conventional dose with transcatheter arterial chemoembolization treat HCC with portal vein tumor thrombus. Methods 32 patients with unresectable HCC complicated with PVTr were performed 3 - dimensional confonmal radiation therapy in conventional dose and TACE. According to the volume of the minors, radiotherapy was performed at an exposure of 2 Gy/time, 5 times/week, DT45 Gy-60 Gy/23-30 times for the larger volume of tumors, PVTr was performed 60 Gy/30 times after finishing the plan of radiotherapy. The objective responses were analyzed and the survival rates were assessed from the date of the begining of treatment using the Kaplan - Meier method. The Cox proportional hazards model was used to analyze the prognostic factors. Results The remission rate of HCC was 68.8%, the remission rate of PVTT was 87.5%. The overal survival rates were 56.3%, 61.3% and 21.9% at 1, 2, 3 years, respectively, with a median survival time of 15 months. Cox proportional hazards model analysis showed that Karnofsky grade and Child- Tureotte-Pugh class were the most important prognostic factors for the survival probability of the patients. The rise of serum transaminase and radiation- induced liver disease were the most treatment - related complications. Conclusion 3 - dimensional confonmal radiation therapy in conventional dose with transcatheter arterial chemoembolization is an effective and feasible approach to treat PVTr in unresectable HCC patients. Kamofsky grade and Child - Turcotte- Pugh class were identified as two predictor for PVTT in unresectable HCC patients.
出处 《实用肿瘤学杂志》 CAS 2006年第3期165-168,共4页 Practical Oncology Journal
关键词 肝肿瘤 门静脉癌栓 三维适形放射治疗 治疗性栓塞 Hepatic neoplasm Portal thrombus 3- Dimensional confommal radiotherapy Therapeutic embolizafion
  • 相关文献

参考文献3

二级参考文献24

  • 1程树群.高功率聚焦超声在肿瘤治疗中的应用[J].国外医学(肿瘤学分册),1994,21(2):74-77. 被引量:21
  • 2陈汉,吴孟超,杨甲梅,王一.如何降低原发性肝癌的复发率[J].中华外科杂志,1994,32(12):768-770. 被引量:3
  • 3张旭光 张临泉 朱迎广 主编.肝癌[A].朱迎广,主编.放射肿瘤学[C].北京: 科学技术文献出版社,2001.354-362.
  • 4Mario Pirisi,Claudio Avellini,Carlo Fabris,Cathryn Scott,Paola Bardus,Giorgio Soardo,Carlo A. Beltrami,Ettore Bartoli.Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study[J].Journal of Cancer Research and Clinical Oncology.1998(7)
  • 5Masao Mitsunobu,Akihiro Toyosaka,Takeshi Oriyama,Eizo Okamoto,Norio Nakao.Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel[J].Clinical & Experimental Metastasis.1996(6)
  • 6Tetsuya Katsumori M.D.,Masato Fujita,Takeshi Takahashi,Osamu Satoh,Shigeki Ichijima,Toshiyuki Nakamura,Hiroyuki Morishita,Kohji Ohno,Yasuhiko Nakano,Tomoho Maeda.Effective segmental chemoembolization of advanced hepatocellular carcinoma with tumor thrombus in the portal vein[J].CardioVascular and Interventional Radiology.1995(4)
  • 7Shinn-Cherng Chen,Shi-Long Lian,Wen-Yu Chang.The effect of external radiotherapy in treatment of portal vein invasion in hepatocellular carcinoma[J].Cancer Chemotherapy and Pharmacology.1994(1)
  • 8Yoshio Yamaoka M.D.,Kaoru Kumada M.D.,Keiichi Ino M.D.,Takashi Takayasu M.D.,Yasuyuki Shimahara M.D.,Keiichiro Mori M.D.,Akira Tanaka M.D.,Taisuke Morimoto M.D.,Yoshiro Taki M.D.,Masanobu Washida M.D.,Dai Manaka M.D.,Michihiro Hayashi M.D.,Takusi Fujita M.D.,Kazue Ozawa M.D.Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein[J].World Journal of Surgery.1992(6)
  • 9Chung JW,Park JH,Hen JK,Choi BI,Hen MC.Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization[].American Journal of Roentgenology.1995
  • 10Engelberg H.Actions of heparin that may affect the malignant process[].Cancer.1999

共引文献251

同被引文献69

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部